Abstract

In radiation oncology, the need for a modern Normal Tissue Complication Probability (NTCP) philosophy to include voxel-based evidence on organ radio-sensitivity (RS) has been acknowledged. Here a new formalism (Probabilistic Atlas for Complication Estimation, PACE) to predict radiation-induced morbidity (RIM) is presented. The adopted strategy basically consists in keeping the structure of a classical, phenomenological NTCP model, such as the Lyman-Kutcher-Burman (LKB), and replacing the dose distribution with a collection of RIM odds, including also significant non-dosimetric covariates, as input of the model framework. The theory was first demonstrated in silico on synthetic dose maps, classified according to synthetic outcomes. PACE was then applied to a clinical dataset of thoracic cancer patients classified for lung fibrosis. LKB models were trained for comparison. Overall, the obtained learning curves showed that the PACE model outperformed the LKB and predicted synthetic outcomes with an accuracy >0.8. On the real patients, PACE performance, evaluated by both discrimination and calibration, was significantly higher than LKB. This trend was confirmed by cross-validation. Furthermore, the capability to infer the spatial pattern of underlying RS map for the analyzed RIM was successfully demonstrated, thus paving the way to new perspectives of NTCP models as learning tools.

Highlights

  • Cancer detection and cancer treatment advances have contributed to improve local tumor control and overall survival

  • The risk of normal tissue complications associated with radiation therapy may even overshadow the benefits provided in terms of tumor control, and many cancer survivors must cope with long-term effects of radiation treatments that negatively affect their quality of life

  • The development of mathematical models for the estimation of Normal Tissue Complication Probability (NTCP) has long been an active field of research in order to predict the PACE–A Voxel-Based NTCP Model risk of radiation-induced morbidity (RIM) from the dose distribution released to critical organs [2, 3]

Read more

Summary

Introduction

Cancer detection and cancer treatment advances have contributed to improve local tumor control and overall survival. By January 1, 2024, it is estimated that in the USA the population of cancer survivors will increase to nearly 19 million individuals [1]. This estimate supports research studies aimed at investigating the quality of life of these patients after the active phase of treatments, and the long-term effects of therapy. The risk of normal tissue complications associated with radiation therapy may even overshadow the benefits provided in terms of tumor control, and many cancer survivors must cope with long-term effects of radiation treatments that negatively affect their quality of life. The development of mathematical models for the estimation of Normal Tissue Complication Probability (NTCP) has long been an active field of research in order to predict the PACE–A Voxel-Based NTCP Model risk of radiation-induced morbidity (RIM) from the dose distribution released to critical organs [2, 3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call